Win-Ping Deng

Title: Win-Ping Deng: Innovator in Cancer Treatment

Introduction

Win-Ping Deng is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on combining protein vaccines with mesenchymal stem cells to inhibit tumor growth and metastasis in mammals.

Latest Patents

Win-Ping Deng holds a patent for a method that involves administering an effective amount of stem cells containing a transgene encoding at least one oncogenic protein. This method is designed to inhibit the growth and/or metastasis of tumors in mammals. The patent also includes a vaccine composition that elicits antibodies specific against the oncogenic protein, thereby providing a therapeutic approach to cancer treatment. This innovative method is encapsulated in his patent titled "Combination of protein vaccine and mesenchymal stem cells for treating cancer," which represents a significant advancement in cancer therapy.

Career Highlights

Throughout his career, Win-Ping Deng has worked with various companies, including Healthbanks Biotech Co., Ltd. and Kooper Biotech Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative approaches to cancer treatment. His dedication to research and development has positioned him as a key figure in the biotechnology sector.

Collaborations

Win-Ping Deng has collaborated with notable professionals in his field, including Hsiu-Kang Chang and Hung-Chien Wei. These collaborations have further enhanced his research and contributed to the advancement of cancer treatment methodologies.

Conclusion

Win-Ping Deng's innovative work in combining protein vaccines with stem cell therapy represents a promising avenue for cancer treatment. His contributions to the field are significant, and his patented methods may pave the way for new therapeutic strategies in oncology.